Clinical Trials Browser

Terminated × Hematologic Neoplasms × tanespimycin × Clear all

NCT01193491 2015-04-15

Dose Escalation of IPI-493 in Hematologic Malignancies

Phase 1 Terminated

Other hematologic neoplasm

Hematologic Neoplasms